“…One of the steroids used in the treatment of breast cancer is exemestane (211), an inhibitor of steroidal aromatase. From the transformation of 211 using Macrophomina phaseolina, 16β,17β-dihydroxy-6-methylene-androsta-1,4-diene-3-one (212), 17β-hydroxy-6-methylene-androsta-1,4-diene-3,16-dione (213), and 17β-hydroxy-6-methylene-androsta-1,4-diene-3-one (214) were obtained, while by using Fusarium lini, the only product obtained was 11α-hydroxy-6-methyleneandrosta-1,4-diene-3,17-dione (215) (Figure 28 products in the C-7 (7α-hydroxymethyltestosterone, 223, 35%) and C-15 (15α-hydroxymethyltestosterone, 224, 21%) positions, plus a dihydroxylated product (12,15α-dihydroxymethyltestosterone, 225, 22%) [100]. Recently, three additional products were identified: 11α-hydroxy-17α-methyltestosterone (226), 6β-hydroxy-17α-methyltestosterone (227), and 6β,11α-dihydroxy-17α-methyltestosterone (228).…”